Author:
Fierro Mary C.,Yafi Faysal A.,Reisman Yacov
Publisher
Springer International Publishing
Reference32 articles.
1. Diviccaro S, Melcangi RC, Giatti S. Post-finasteride syndrome: an emerging clinical problem. Neurobiol Stress. 2020;12:100209. https://doi.org/10.1016/j.ynstr.2019.100209.
2. Propecia. Letters, reviews, labels, patient package insert. Merck; 1997. Accessed June 6, 2021. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020788.
3. Post-Finasteride Syndrome Foundation. https://www.pfsfoundation.org. Accessed 3 Jun 2021.
4. Baas WR, Butcher MJ, Lwin A, Holland B, Herberts M, Clemons J, et al. A review of the FAERS data on 5-alpha reductase inhibitors: implications for postfinasteride syndrome. Urology. 2018;120:143–9. https://doi.org/10.1016/j.urology.2018.06.022.
5. National Institutes of Health. National Center for Advancing Translational Sciences. Genetic and Rare Diseases Information Center. https://rarediseases.info.nih.gov/diseases/12407/post-finasteride-syndrome Accessed 2 June 2021.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献